2014 News

August 19, 2014

Morphotek and Downingtown STEM Academy Partner on Shadow Program
Read More

July 7, 2014

Stealth Biologics Initiates Biotherapeutic Deimmunization Program with Morphotek
Read More

June 25, 2014

Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to Generate and Develop Morphotek Antibody Drug Conjugates
Read More

January 22, 2014

European Commission Grants Orphan Drug Status to Eisai's Amatuximab for the Treatment of Malignant Mesothelioma
Read More

News & Events > News Archive > 2014 News